Apogee Therapeutics, Inc. APGE Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s change in lease liabilities?
- Apogee Therapeutics, Inc. (APGE) reported change in lease liabilities of -$802K in Q1 2026.
- How has Apogee Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Apogee Therapeutics, Inc.'s change in lease liabilities increased by 20.9% year-over-year, from -$1.01M to -$802K.
- What is the long-term trend for Apogee Therapeutics, Inc.'s change in lease liabilities?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s change in lease liabilities has grown at a 284.0% compound annual growth rate (CAGR), from -$270K to -$3.98M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.